首页> 外文期刊>Pharmacoepidemiology and drug safety >A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001(,).
【24h】

A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001(,).

机译:肠胃外灭活流感疫苗后贝尔麻痹的潜在信号:向美国疫苗不良事件报告系统(VAERS)的报告,1991-2001(,)。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: Post-licensure experience with a new intranasal inactivated influenza vaccine in Switzerland recently identified an increased risk for Bell's palsy. We reviewed reports in the Vaccine Adverse Event Reporting System (VAERS) to assess if parenteral inactivated influenza vaccines (influenza vaccines) may also increase the risk for Bell's palsy. METHODS: Reports of Bell's palsy after influenza vaccines in VAERS from 1/1/1991 to 12/31/2001 were identified by searching the Coding Symbols for Thesaurus of Adverse Reaction Terms (COSTART) for 'paralysis facial' and by text string search in the automated database. The text descriptions on each report were reviewed to verify the diagnosis. The proportional reporting ratio (PRR) was calculated to aid signal detection. RESULTS: We found a total of 197 reports of Bell's palsy after receipt of influenza vaccines. The diagnosis was verified for 154 (78.2%), of which 145 (94.2%) had received influenza vaccines alone. The verified reports were submitted from 35 states; 58% of the reports involved persons living in states where the risk of Lyme disease, which can also cause facial paralysis, was low, minimal or none. The PRRs in all age groups exceeded the criteria for a signal of possible association. The highest PRR was 3.91 in the >/=65 years age group. CONCLUSIONS: Our findings revealed a signal of possible association between influenza vaccines and an increased risk of Bell's palsy. A population-based controlled study is needed to determine whether this association could be causal and to quantify the risk. Published in 2004 by John Wiley & Sons, Ltd.
机译:目的:在瑞士使用新的鼻内灭活流感疫苗进行许可后的经验最近确定了贝尔麻痹的风险增加。我们审查了疫苗不良事件报告系统(VAERS)中的报告,以评估肠胃外灭活的流感疫苗(流感疫苗)是否也可能增加贝尔麻痹的风险。方法:通过搜索不良反应词库(COSTART)的“瘫痪面部”的符号和文本字符串搜索来识别1991年1月1日至2001年12月31日在VAERS中接种流感疫苗后贝尔麻痹的报告。自动化数据库。审查了每个报告上的文字说明以验证诊断。计算比例报告比率(PRR)以帮助信号检测。结果:我们在收到流感疫苗后共发现197例贝尔氏麻痹的报告。确诊154例(78.2%),其中145例(94.2%)仅接受流感疫苗。核实的报告是从35个州提交的; 58%的报告涉及居住在莱姆病(也可能引起面部麻痹)的风险低,极少或根本没有的州。所有年龄段的PRR均超出可能关联信号的标准。 > / = 65岁年龄组的最高PRR为3.91。结论:我们的发现揭示了流感疫苗与贝尔麻痹风险增加之间可能存在关联的信号。需要进行基于人群的对照研究,以确定这种关联是否是因果关系并量化风险。 John Wiley&Sons,Ltd.于2004年出版。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号